Brown Advisory Inc. bought a new position in ICU Medical, Inc. (NASDAQ:ICUI) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,803 shares of the medical instruments supplier’s stock, valued at approximately $335,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Schwab Charles Investment Management Inc. increased its stake in ICU Medical by 7.8% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 67,391 shares of the medical instruments supplier’s stock worth $12,525,000 after acquiring an additional 4,873 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in shares of ICU Medical by 0.9% in the 3rd quarter. Wells Fargo & Company MN now owns 560,756 shares of the medical instruments supplier’s stock worth $104,217,000 after purchasing an additional 5,044 shares in the last quarter. Citadel Advisors LLC purchased a new position in shares of ICU Medical in the 3rd quarter worth about $18,135,000. JPMorgan Chase & Co. boosted its holdings in shares of ICU Medical by 3.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 432,281 shares of the medical instruments supplier’s stock worth $80,122,000 after purchasing an additional 14,537 shares in the last quarter. Finally, Legal & General Group Plc boosted its holdings in shares of ICU Medical by 3.8% in the 3rd quarter. Legal & General Group Plc now owns 29,918 shares of the medical instruments supplier’s stock worth $5,561,000 after purchasing an additional 1,087 shares in the last quarter. Institutional investors and hedge funds own 78.15% of the company’s stock.
A number of equities analysts have recently issued reports on the company. Zacks Investment Research upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. BidaskClub upgraded ICU Medical from a “sell” rating to a “hold” rating in a report on Friday, August 18th. Finally, KeyCorp assumed coverage on ICU Medical in a report on Tuesday, October 17th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $232.00.
Shares of ICU Medical, Inc. (NASDAQ ICUI) opened at $210.40 on Tuesday. The firm has a market capitalization of $4,243.52, a PE ratio of 82.67, a P/E/G ratio of 3.38 and a beta of 0.36. ICU Medical, Inc. has a fifty-two week low of $127.00 and a fifty-two week high of $218.45. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07.
ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, November 9th. The medical instruments supplier reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.35. The company had revenue of $343.20 million during the quarter, compared to analysts’ expectations of $328.56 million. ICU Medical had a return on equity of 4.81% and a net margin of 2.79%. ICU Medical’s quarterly revenue was up 253.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.35 EPS. equities analysts predict that ICU Medical, Inc. will post 3.95 earnings per share for the current fiscal year.
In related news, Director Robert S. Swinney sold 463 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $181.25, for a total transaction of $83,918.75. Following the completion of the sale, the director now directly owns 14,330 shares in the company, valued at approximately $2,597,312.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Vivek Jain sold 2,200 shares of the stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $190.91, for a total value of $420,002.00. Following the sale, the chief executive officer now owns 44,111 shares of the company’s stock, valued at $8,421,231.01. The disclosure for this sale can be found here. Insiders have sold a total of 119,663 shares of company stock valued at $22,887,437 over the last 90 days. 13.60% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: “Brown Advisory Inc. Buys Shares of 1,803 ICU Medical, Inc. (ICUI)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/12/12/brown-advisory-inc-buys-shares-of-1803-icu-medical-inc-icui.html.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.